AR033260A1 - NEW HORMONAL COMPOSITION AND ITS USE - Google Patents
NEW HORMONAL COMPOSITION AND ITS USEInfo
- Publication number
- AR033260A1 AR033260A1 ARP020101475A ARP020101475A AR033260A1 AR 033260 A1 AR033260 A1 AR 033260A1 AR P020101475 A ARP020101475 A AR P020101475A AR P020101475 A ARP020101475 A AR P020101475A AR 033260 A1 AR033260 A1 AR 033260A1
- Authority
- AR
- Argentina
- Prior art keywords
- compound
- estrogenic
- association
- new
- stroprogestative
- Prior art date
Links
- 230000003054 hormonal effect Effects 0.000 title abstract 3
- 239000000203 mixture Substances 0.000 title abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 5
- 230000001076 estrogenic effect Effects 0.000 abstract 3
- 238000000034 method Methods 0.000 abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 abstract 2
- 208000001132 Osteoporosis Diseases 0.000 abstract 1
- 230000007812 deficiency Effects 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 229940011871 estrogen Drugs 0.000 abstract 1
- 239000000262 estrogen Substances 0.000 abstract 1
- 231100000252 nontoxic Toxicity 0.000 abstract 1
- 230000003000 nontoxic effect Effects 0.000 abstract 1
- 239000000546 pharmaceutical excipient Substances 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/30—Oestrogens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/34—Gestagens
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Endocrinology (AREA)
- Engineering & Computer Science (AREA)
- Diabetes (AREA)
- Epidemiology (AREA)
- Reproductive Health (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Steroid Compounds (AREA)
Abstract
Dominio de la química terapéutica, y más particularmente dominio de la técnica farmacéutica hormonal. Nuevas composiciones farmacéuticas hormonales formadas por una asociacion estroprogestativa constituida por un compuesto estrogeno y un compuesto progestativo, en asociacion o mezclado con varios excipientes no toxicos, inertes, farmacéuticamente aceptables, destinadas a la administracion por vía bucal.Uso de una mezcla estroprogestativa en que el compuesto estrogénico y el compuesto progestativo se administran de una manera combinada la asociacion combinada puede ser prescripta de una manera continua o intermitente mediante la preparacion de un compuesto destinado al tratamiento de carencias estrogénicas, evitar la osteoporosis y las enfermedades, en la mujer menopáusica. Un procedimiento para la preparacion de estas nuevas composiciones farmacéuticas estroprogestativas.Mastery of therapeutic chemistry, and more particularly mastery of the hormonal pharmaceutical technique. New hormonal pharmaceutical compositions formed by a stroprogestative association consisting of an estrogen compound and a progestative compound, in association or mixed with several non-toxic, inert, pharmaceutically acceptable excipients, intended for oral administration.Use of a stroprogestative mixture in which the estrogenic compound and the progestative compound are administered in a combined manner the combined association can be prescribed in a continuous or intermittent manner by preparing a compound intended for the treatment of estrogenic deficiencies, avoiding osteoporosis and diseases, in the menopausal woman. A procedure for the preparation of these new estrogenic pharmaceutical compositions.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0105557A FR2823976A1 (en) | 2001-04-25 | 2001-04-25 | NOVEL HORMONAL COMPOSITION AND ITS USE |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR033260A1 true AR033260A1 (en) | 2003-12-10 |
Family
ID=8862668
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP020101475A AR033260A1 (en) | 2001-04-25 | 2002-04-24 | NEW HORMONAL COMPOSITION AND ITS USE |
Country Status (9)
| Country | Link |
|---|---|
| KR (1) | KR20030043797A (en) |
| CN (1) | CN1464787A (en) |
| AR (1) | AR033260A1 (en) |
| AU (1) | AU2002310721A1 (en) |
| BR (1) | BR0205104A (en) |
| FR (1) | FR2823976A1 (en) |
| MA (1) | MA26833A1 (en) |
| NO (1) | NO20026215L (en) |
| WO (1) | WO2002085375A1 (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8022053B2 (en) | 2004-11-02 | 2011-09-20 | Bayer Schering Pharma Aktiengesellschaft | Oral solid dosage forms containing a low dose of estradiol |
| UY29185A1 (en) * | 2004-11-02 | 2006-05-31 | Schering Ag | SOLID ORAL DOSAGE FORMS CONTAINING A LOW ESTRADIOL DOSE |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4826831A (en) * | 1983-08-05 | 1989-05-02 | Pre Jay Holdings Limited | Method of hormonal treatment for menopausal or post-menopausal disorders involving continuous administration of progestogens and estrogens |
| US5208225A (en) * | 1986-02-27 | 1993-05-04 | Warner-Lambert Company | Compositions containing fixed combinations |
| FR2754179B1 (en) * | 1996-10-08 | 1998-12-24 | Theramex | NOVEL HORMONONAL COMPOSITION AND ITS USE |
-
2001
- 2001-04-25 FR FR0105557A patent/FR2823976A1/en not_active Withdrawn
-
2002
- 2002-04-15 MA MA26603A patent/MA26833A1/en unknown
- 2002-04-23 KR KR1020027017624A patent/KR20030043797A/en not_active Withdrawn
- 2002-04-23 CN CN02802212A patent/CN1464787A/en active Pending
- 2002-04-23 AU AU2002310721A patent/AU2002310721A1/en not_active Abandoned
- 2002-04-23 WO PCT/FR2002/001384 patent/WO2002085375A1/en not_active Ceased
- 2002-04-23 BR BR0205104-4A patent/BR0205104A/en not_active Application Discontinuation
- 2002-04-24 AR ARP020101475A patent/AR033260A1/en not_active Application Discontinuation
- 2002-12-23 NO NO20026215A patent/NO20026215L/en not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| NO20026215D0 (en) | 2002-12-23 |
| KR20030043797A (en) | 2003-06-02 |
| CN1464787A (en) | 2003-12-31 |
| AU2002310721A1 (en) | 2002-11-05 |
| BR0205104A (en) | 2003-05-20 |
| NO20026215L (en) | 2003-02-21 |
| FR2823976A1 (en) | 2002-10-31 |
| WO2002085375A8 (en) | 2003-02-20 |
| WO2002085375A1 (en) | 2002-10-31 |
| MA26833A1 (en) | 2004-12-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EA200201000A1 (en) | HORMONE-DESTINY THERAPY | |
| EA200900491A1 (en) | USE OF ESTRADIOL VALERAT OR 17B-ESTRADIOL IN COMBINATION WITH DIENOGEST FOR ORAL TREATMENT TO MAINTAIN AND / OR INCREASE SEXUAL TREATMENT IN THE SPECIAL WOMAN | |
| EA200301022A1 (en) | HORMONAL REPLACEMENT THERAPY | |
| EA200600964A1 (en) | PHARMACEUTICAL PREPARATION FOR CONTINUOUS HORMONAL TREATMENT DURING A LONGER LONGER THAN 21-4 DAYS, INCLUDING TWO ESTROGEN AND / OR PROGESTINE COMPOSITIONS | |
| EA200600029A1 (en) | PHARMACEUTICAL COMPOSITION FOR CONTRACEPTION AND SUBSTITUTIONAL HORMONAL THERAPY | |
| CR7420A (en) | PHARMACEUTICAL COMPOSITIONS THAT INCLUDE ONE OR VARIOUS STEROIDS, ONE OR VARIOUS COMPONENTS OF TETRAHIIDROPHOLATES AND VITAMIN B12 | |
| BRPI0412493A (en) | Hormonal treatment methods using contraceptive regimens with continuous estrogen administration | |
| AP1849A (en) | Dosage regimen and pharmaceutical composition for emergency contraception | |
| MY128482A (en) | New hormonal composition and its use | |
| AP1625A (en) | Hormonal composition based on a progesterone and an oestrogen and use thereof. | |
| BR0114665A (en) | Use of antiprogestins for prophylaxis and treatment of hormone dependent diseases | |
| AR046036A1 (en) | RISEDRONATE COMPOSITIONS AND METHODS FOR USE | |
| AR035946A1 (en) | PHARMACEUTICAL COMPOSITIONS TO USE IN THE TREATMENT OF DISORDERS IN WOMEN PERIMENOPAUSIC, MENOPAUSIC OR POSMENOPAUSIC, AND USES OF SUCH COMPOSITIONS FOR THE PREPARATION OF MEDICINES | |
| AR033260A1 (en) | NEW HORMONAL COMPOSITION AND ITS USE | |
| CR6627A (en) | NEW CONTRACEPTIVE MEDICINAL PRODUCT AND ITS PREPARATION MODE | |
| HUP0004461A2 (en) | Use of apolipoprotein b secretion/microsomal triglyceride transfer protein inhibitor for producing pharmaceutical composition and these pharmaceutical compositions | |
| AR039227A1 (en) | HORMONAL REPLACEMENT THERAPY | |
| EA201000097A1 (en) | 8-BETA-SUBSTITUTED ESTRATRIENES AS A SELECTIVE ACTIVE STROGEN | |
| AR039228A1 (en) | HORMONAL REPLACEMENT THERAPY | |
| JP2005532336A5 (en) | ||
| AR039477A1 (en) | HORMONAL REPLACEMENT THERAPY | |
| DK1462107T3 (en) | Method of female contraception and kit for use in such a method | |
| CR6628A (en) | NEW HORMONAL COMPOSITION AND ITS USE | |
| HRP20020666B1 (en) | DROSPIRENON FOR HORMONAL REPLACEMENT THERAPY | |
| AR044184A1 (en) | METHOD FOR THE THERAPEUTIC MANAGEMENT OF THE EXTRAUTERINE PROLIFERATION OF ENDOMETRIAL FABRIC, CHRONIC PELVIC PAIN AND OBSTRUCTION OF PHALOPIO TRUMPS, PHARMACEUTICAL COMPOSITIONS USEFUL FOR THE APPLICATION OF SUCH METHOD AND THE USE OF A PREPARATION OF A MEDIA |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |